Circulation:TC/HDL-C有望为LDL-C和非HDL-C提供潜在额外信息

2015-07-22 高晓方 译 医学论坛网

从标准脂质谱中可常规获取总胆固醇/高密度脂蛋白胆固醇(TC/HDL-C)比、估计低密度脂蛋白胆固醇(LDL-C)和非HDL-C。美国一项研究表明,在接受先进脂质检测的美国成人当前横断面大数据分析中,患者水平不一致性程度提示TC/HDL-C有望为LDL-C和非HDL-C提供潜在的额外信息;未来需行进一步的研究以确定此观察结果的临床意义。相关论文7月2日在线发表于《循环》(Circulation)。

从标准脂质谱中可常规获取总胆固醇/高密度脂蛋白胆固醇(TC/HDL-C)比、估计低密度脂蛋白胆固醇(LDL-C)和非HDL-C。美国一项研究表明,在接受先进脂质检测的美国成人当前横断面大数据分析中,患者水平不一致性程度提示TC/HDL-C有望为LDL-C和非HDL-C提供潜在的额外信息;未来需行进一步的研究以确定此观察结果的临床意义。相关论文7月2日在线发表于《循环》(Circulation)。

此项研究从极大型脂质数据库中纳入1310432例成人受试者,并对TC/HDL-C、Friedewald估计LDL-C和非HDL-C人群百分位数进行了比较。采用超速离心法实施脂质检测。由于不一致性提示可能存在附加信息,因此对TC/HDL-C与LDL-C和非HDL-C的患者水平不一致程度加以评估。

结果显示,3例患者中有1例伴有TC/HDL-C和LDL-C之间≥25百分位数的不一致性;4例患者中有1例伴有TC/HDL-C和非HDL-C之间≥25百分位数的不一致性。当甘油三酯<100 mg/dL时,TC/HDL-C 大于LDL-C≥25百分位数的患者比率为3%;当甘油三酯为200~399 mg/dL时则升高至51%。TC/HDL-C 大于非HDL-C不一致性≥25百分位数的患者比率相应为6%和21%,升高幅度相对较少。在LDL-C(<70 mg/dL)或非HDL-C(<93 mg/dL)<15百分位数水平的患者中,超出TC/HDL-C 2.6百分位数当量者分别为58%和46%。年龄、性别和标准脂质谱中直接测定组分可解释>86%的TC/HDL-C与LDL-C和非HDL-C百分位数不一致性差异。

原始出处:

Mohamed B. Elshazly ,et al.CIRCULATIONAHA. 115.016163 Published online before print July 2, 2015,doi: 10.1161/CIRCULATIONAHA.115.016163

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1819080, encodeId=40d3181908084, content=<a href='/topic/show?id=8d08992182d' target=_blank style='color:#2F92EE;'>#非HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99218, encryptionId=8d08992182d, topicName=非HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 20 15:08:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33455, encodeId=e1c6334552d, content=就是这么几个指标来回弄, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Jul 25 09:51:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33401, encodeId=b8093340164, content=比值比单独看某一项指标更有临床意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4831631456, createdName=psychedeng, createdTime=Fri Jul 24 10:14:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316410, encodeId=f2221316410f3, content=<a href='/topic/show?id=73f386080a' target=_blank style='color:#2F92EE;'>#HDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8608, encryptionId=73f386080a, topicName=HDL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422524, encodeId=f1d51422524bb, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480816, encodeId=7603148081627, content=<a href='/topic/show?id=edd28609dd' target=_blank style='color:#2F92EE;'>#HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8609, encryptionId=edd28609dd, topicName=HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0a97689161, createdName=ms920641618706883, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=)]
    2016-04-20 xugumin
  2. [GetPortalCommentsPageByObjectIdResponse(id=1819080, encodeId=40d3181908084, content=<a href='/topic/show?id=8d08992182d' target=_blank style='color:#2F92EE;'>#非HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99218, encryptionId=8d08992182d, topicName=非HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 20 15:08:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33455, encodeId=e1c6334552d, content=就是这么几个指标来回弄, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Jul 25 09:51:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33401, encodeId=b8093340164, content=比值比单独看某一项指标更有临床意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4831631456, createdName=psychedeng, createdTime=Fri Jul 24 10:14:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316410, encodeId=f2221316410f3, content=<a href='/topic/show?id=73f386080a' target=_blank style='color:#2F92EE;'>#HDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8608, encryptionId=73f386080a, topicName=HDL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422524, encodeId=f1d51422524bb, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480816, encodeId=7603148081627, content=<a href='/topic/show?id=edd28609dd' target=_blank style='color:#2F92EE;'>#HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8609, encryptionId=edd28609dd, topicName=HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0a97689161, createdName=ms920641618706883, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=)]
    2015-07-25 Messichen1992

    就是这么几个指标来回弄

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1819080, encodeId=40d3181908084, content=<a href='/topic/show?id=8d08992182d' target=_blank style='color:#2F92EE;'>#非HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99218, encryptionId=8d08992182d, topicName=非HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 20 15:08:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33455, encodeId=e1c6334552d, content=就是这么几个指标来回弄, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Jul 25 09:51:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33401, encodeId=b8093340164, content=比值比单独看某一项指标更有临床意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4831631456, createdName=psychedeng, createdTime=Fri Jul 24 10:14:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316410, encodeId=f2221316410f3, content=<a href='/topic/show?id=73f386080a' target=_blank style='color:#2F92EE;'>#HDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8608, encryptionId=73f386080a, topicName=HDL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422524, encodeId=f1d51422524bb, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480816, encodeId=7603148081627, content=<a href='/topic/show?id=edd28609dd' target=_blank style='color:#2F92EE;'>#HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8609, encryptionId=edd28609dd, topicName=HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0a97689161, createdName=ms920641618706883, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=)]
    2015-07-24 psychedeng

    比值比单独看某一项指标更有临床意义吗?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1819080, encodeId=40d3181908084, content=<a href='/topic/show?id=8d08992182d' target=_blank style='color:#2F92EE;'>#非HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99218, encryptionId=8d08992182d, topicName=非HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 20 15:08:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33455, encodeId=e1c6334552d, content=就是这么几个指标来回弄, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Jul 25 09:51:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33401, encodeId=b8093340164, content=比值比单独看某一项指标更有临床意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4831631456, createdName=psychedeng, createdTime=Fri Jul 24 10:14:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316410, encodeId=f2221316410f3, content=<a href='/topic/show?id=73f386080a' target=_blank style='color:#2F92EE;'>#HDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8608, encryptionId=73f386080a, topicName=HDL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422524, encodeId=f1d51422524bb, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480816, encodeId=7603148081627, content=<a href='/topic/show?id=edd28609dd' target=_blank style='color:#2F92EE;'>#HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8609, encryptionId=edd28609dd, topicName=HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0a97689161, createdName=ms920641618706883, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=)]
    2015-07-24 ZGMFX24A
  5. [GetPortalCommentsPageByObjectIdResponse(id=1819080, encodeId=40d3181908084, content=<a href='/topic/show?id=8d08992182d' target=_blank style='color:#2F92EE;'>#非HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99218, encryptionId=8d08992182d, topicName=非HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 20 15:08:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33455, encodeId=e1c6334552d, content=就是这么几个指标来回弄, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Jul 25 09:51:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33401, encodeId=b8093340164, content=比值比单独看某一项指标更有临床意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4831631456, createdName=psychedeng, createdTime=Fri Jul 24 10:14:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316410, encodeId=f2221316410f3, content=<a href='/topic/show?id=73f386080a' target=_blank style='color:#2F92EE;'>#HDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8608, encryptionId=73f386080a, topicName=HDL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422524, encodeId=f1d51422524bb, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480816, encodeId=7603148081627, content=<a href='/topic/show?id=edd28609dd' target=_blank style='color:#2F92EE;'>#HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8609, encryptionId=edd28609dd, topicName=HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0a97689161, createdName=ms920641618706883, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=)]
    2015-07-24 zhwj
  6. [GetPortalCommentsPageByObjectIdResponse(id=1819080, encodeId=40d3181908084, content=<a href='/topic/show?id=8d08992182d' target=_blank style='color:#2F92EE;'>#非HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99218, encryptionId=8d08992182d, topicName=非HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 20 15:08:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33455, encodeId=e1c6334552d, content=就是这么几个指标来回弄, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Jul 25 09:51:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33401, encodeId=b8093340164, content=比值比单独看某一项指标更有临床意义吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4831631456, createdName=psychedeng, createdTime=Fri Jul 24 10:14:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316410, encodeId=f2221316410f3, content=<a href='/topic/show?id=73f386080a' target=_blank style='color:#2F92EE;'>#HDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8608, encryptionId=73f386080a, topicName=HDL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fb6449, createdName=ZGMFX24A, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422524, encodeId=f1d51422524bb, content=<a href='/topic/show?id=58b810e5814' target=_blank style='color:#2F92EE;'>#LDL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10758, encryptionId=58b810e5814, topicName=LDL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=382c3719677, createdName=zhwj, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480816, encodeId=7603148081627, content=<a href='/topic/show?id=edd28609dd' target=_blank style='color:#2F92EE;'>#HDL-C#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8609, encryptionId=edd28609dd, topicName=HDL-C)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0a97689161, createdName=ms920641618706883, createdTime=Fri Jul 24 00:08:00 CST 2015, time=2015-07-24, status=1, ipAttribution=)]

相关资讯

“后立普妥时代”,谁是下一个赢家

  随着全球医药市场的快速发展,辉煌了18年的立普妥在专利到期后,已成为昨日之星。辉瑞公司财务报表显示,2014年一季度全球立普妥市场为4.57亿美元,同比上一年同期下降了27%;在美国市场仅为0.5亿美元,同比上一年同期下降了71%,而在美国以外的市场为4.07亿美元,仍比上一年同期下降了11%。 在立普妥专利到期前,辉瑞已进行了调血脂新药的研发。但不幸的是辉瑞的Torcetr

.J Am Heart Assoc:不同人群高胆固醇血症的知晓率、治疗率和控制率差异

美国学者们近期对西班牙/拉丁美洲人高胆固醇血症(HC)的认识、管理和控制情况进行了评估。 研究者们分析了16207例西班牙/拉丁美洲成人的多点概率样本(年龄18至74岁)基线数据。以低密度脂蛋白胆固醇≥130 mg/dL和/或总胆固醇≥240 mg/dL或应用降胆固醇药物定义为HC。 结果显示,在西班牙/拉丁美洲HC成人中,近半数人群未意识到自己的状况,仅29.5%的人群接受了治疗。 与女性

EHJ:儿童和青少年家族性高胆固醇血症的管理

家族性高胆固醇血症(FH)是早产儿冠心病(CHD)的常见遗传原因。全球每分钟就有一例FH婴儿出生。如果在儿童早期阶段进行诊断和治疗,FH个体可有正常人的预期寿命。5月25日,《欧洲心脏杂志》(Eur Heart J)刊文阐述了FH的早期检测和管理策略。FH的诊断文章指出,可通过表型标准和/或遗传诊断或基因检测来诊断FH,前者包括低密度脂蛋白胆固醇(L

指南:中国缺血性脑卒中血脂管理指导规范

卒中已经成为我国人口死亡和致残的第一位原因,最新报道 2010年中国年卒中死亡人数髙达170万,我国缺血性卒中患者第一年的复发率高达17.7%,显著高于西方国家。脑卒中的高发病率、高死亡率和高致残率给我国的社会经济发展带来沉重负担。  血脂异常是缺血性卒中/短暂性脑缺血发作(TIA)的重要危险因素,而对不同类型卒中进行分析发现,血清总胆固醇水平升高与缺血性卒中的发生密切相关。在冠心病人群中,随着血